Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy

Immunotherapy includes immune checkpoint inhibitors (ICI) such as antibodies targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) or the programmed cell death protein/programmed death ligand 1 (PD-1/PD-L1) axis. Experimental and clinical evidence show that immunotherapy based on immune che...

Descripción completa

Detalles Bibliográficos
Autores principales: Benoit, Alice, Vogin, Guillaume, Duhem, Caroline, Berchem, Guy, Janji, Bassam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341162/
https://www.ncbi.nlm.nih.gov/pubmed/37443821
http://dx.doi.org/10.3390/cells12131787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341162/
https://www.ncbi.nlm.nih.gov/pubmed/37443821
http://dx.doi.org/10.3390/cells12131787

Ejemplares similares